Skip to content

Validation of an Intracycle CT Motion CORrection Algorithm for Diagnostic AccuracY

Validation of an Intracycle CT Motion CORrection Algorithm for Diagnostic AccuracY: A Prospective Multicenter Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01856504
Acronym
VICTORY
Enrollment
218
Registered
2013-05-17
Start date
2013-05-31
Completion date
2015-03-31
Last updated
2015-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Arteriosclerosis, Coronary Artery Disease

Keywords

Heart Disease, Coronary Artery Disease, Coronary Arteriosclerosis

Brief summary

To demonstrate the incremental utility of SSF for individuals undergoing CCTA, with expected improvements in image quality and diagnostic accuracy.

Detailed description

Hypothesis: Coronary CT angiography (CCTA) employing a novel intracycle motion compensation algorithm (SnapShot Freeze \[SSF\]) will be superior to CCTA without an intracycle motion compensation algorithm (conventional CCTA) for diagnostic accuracy and image quality. Scientific Basis: Preliminary study (Leipsic, Min, Journal of Cardiovascular Computed Tomography \[in press\]) of coronary CT angiograms in individuals undergoing pre-procedural assessment for transcatheter aortic valve replacement (n=36) demonstrate improved image quality of CCTA using SSF compared to CCTA not using SSF. Importantly, individuals in this study did not receive heart rate slowing agents (e.g., beta blockers), and diagnostic image quality was substantially improved. While not statistically powered on a per-patient basis, per-segment diagnostic accuracy of CCTA using SSF was superior to conventional CCTA. These results are complementary to those derived from internal testing at GE Healthcare wherein phantom work has demonstrated improved diagnostic performance using SSF compared to conventional image acquisitions. Long-term Goal/Purpose: To demonstrate the incremental utility of SSF for individuals undergoing CCTA, with expected improvements in image quality and diagnostic accuracy. If the aims of this study are achieved, the use of SSF for effective temporal resolution improvement may obviate (or reduce) the need for CT hardware for improved temporal resolution.

Interventions

None listed

Sponsors

GE Healthcare
CollaboratorINDUSTRY
MDDX LLC
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Consenting adult patients ≥18 years of age; 2. Suspected but without known prior history of CAD 3. Not actively taking heart rate lowering agents at least 48 hours prior to study (e.g., AV nodal blockers such as beta blockers, calcium channel blockers or digoxin) 4. Glomerular filtration rate \>60 ml/min 5. CCTA and ICA within 1 week of each other with no interscan event (e.g., myocardial infarction or coronary revascularization)

Exclusion criteria

1. Incomplete ICA or CCTA; 2. Known CAD (prior myocardial infarction, PCI, CABG) 3. Atrial Fibrillation 4. Abnormal Renal Function (GFR \<60 ml/min) 5. Unwilling or unable to give consent 6. Non-cardiac illness with life expectancy \<1 year 7. Concomitant participation in another clinical trial in which subject is subject to investigational drug or device 8. Pregnant women 9. Allergy to iodinated contrast agent 10. Contraindications to nitroglycerin 11. Systolic blood pressure ≤90 mm Hg 12. Contraindications to β blockers or nitroglycerin

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic Accuracy30 daysTo compare the per-patient, per-vessel and per-segment diagnostic accuracy of CCTA with SSF to conventional CCTA, as compared to invasive quantitative coronary angiography.
Diagnostic Interpretability30 daysTo compare the per-patient, per-vessel and per-segment diagnostic interpretability of CCTA with SSF to conventional CCTA, as compared to invasive quantitative coronary angiography.
Image quality30 dayTo compare the per-patient, per-vessel and per-segment quantitative image quality of CCTA with SSF to conventional CCTA, as compared to invasive quantitative coronary angiography.

Secondary

MeasureTime frameDescription
Upper threshold of heart rate1 dayTo determine the upper threshold of heart rate below which CCTA with SSF is most effective.
incremental & additive value1 dayTo determine the incremental & additive value of SSF to conventional CCTA for diagnostic accuracy / diagnostic interpretability / image quality.

Countries

Argentina, Canada, India, Italy, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026